{{PBB|geneid=1956}}
'''表皮生长因子受体'''（{{lang-en|epidermal growth factor receptor}}，简称为'''EGFR'''、'''ErbB-1'''或'''HER1'''）是一类名为[[表皮生长因子|表皮生长因子]]家族（EGF-家族）的[[细胞外|细胞外]]蛋白[[配体_(生物化学)|配体]]的[[细胞膜|细胞表面]][[受体_(生物化学)|受体]]<ref name="pmid15142631">{{cite journal | author = Herbst RS | title = Review of epidermal growth factor receptor biology | journal = Int. J. Radiat. Oncol. Biol. Phys. | volume = 59 | issue = 2 Suppl | pages = 21–6 | year = 2004 | pmid = 15142631 | doi = 10.1016/j.ijrobp.2003.11.041 }}</ref> 。

表皮生长因子受体是[[ErbB|ErbB受体家族]]家族的成员之一，ErbB家族是包含四种紧密联系蛋白的亚家族，这四种蛋白分别是[[受体酪氨酸激酶|受体酪氨酸激酶]]类：EGFR（ErbB-1）、[[HER2/neu|HER2/c-neu]]（ErbB-2）、[[ERBB3|Her 3]]（ErbB-3）以及[[Her_4|Her 4]]（ErbB-4）。影响EGFR表达或活性的突变可能导致[[癌症|癌症]]<ref name="pmid17671639">{{cite journal | author = Zhang H, Berezov A, Wang Q, Zhang G, Drebin J, Murali R, Greene MI | title = ErbB receptors: from oncogenes to targeted cancer therapies | url = https://archive.org/details/sim_journal-of-clinical-investigation_2007-08_117_8/page/2051 | journal = J. Clin. Invest. | volume = 117 | issue = 8 | pages = 2051–8 | pmid = 17671639 | pmc = 1934579 | doi = 10.1172/JCI32278 |date=August 2007}}</ref>。

表皮生长因子及其受体是由[[范德堡大学|范德堡大学]]的[[斯坦利·科恩|斯坦利·科恩]]发现的，科恩与[[丽塔·列维-蒙塔尔奇尼|丽塔·列维-蒙塔尔奇尼]]因发现[[生长因子|生长因子]]类而共同获得了1986年[[诺贝尔生理学或医学奖|诺贝尔生理学或医学奖]]。

== 功能 ==
[[Image:EGFR_signaling_pathway_(zh-cn).svg|left]]
表皮生长因子受体（EGFR）存在于细胞表面且因结合特异性[[受体|受体]]而被激活，这些受体包括[[表皮生长因子|表皮生长因子]]和[[转化生长因子-α|转化生长因子-α]]。ErbB2并无已知的直接激活配体，可能结构性地处于激活状态，或在与如EGFR等其他家族成员形成异源二聚体时被激活。
除了參與正常的生理功能之外，EGFR在癌症中同樣扮演了重要的角色，以非小細胞性肺癌(NSCLC)為例，在全球患有非小細胞性肺癌的病患中，高達20%都表現了EGFR基因的突變，所以目前的藥物多朝向EGFR tyrosine kinase inhibitor去做設計，以期達到治療的效果。
<ref>{{cite journal |author1=Yuhong Lu , Yanfeng Liu , Sebastian Oeck , Gary J. Zhang , Alexander Schramm , and Peter M. Glazer |title=Hypoxia Induces Resistance to EGFR Inhibitors in Lung Cancer Cells via Upregulation of FGFR1 and the MAPK Pathway |journal=Cancer Res |date=2020-11-01|volume=80 |issue=21 |page=4655-4667 |doi=10.1158/0008-5472.CAN-20-1192}}</ref>
目前發現具有EGFR突變型的NSCLC癌細胞會對tyrosine kinase inhibitor產生抗藥作用，這個抗藥作用可能來自於其中細胞大量的endothelin表現，進而使腫瘤組織血管收縮，降低了抗癌藥物的灌流，產生類似抗藥性的效果。
<ref>{{cite journal |author1=A.A. Armour, C.L. Watkins  |title=The challenge of targeting EGFR: experience with gefitinib in non small cell lung cancer |journal=Cancer Res |date=2020-10-01|volume=80 |issue=19 |page=4023-4024 |doi=10.1158/0008-5472.CAN-20-0141}}</ref>

==参考文献==
{{Reflist|2}}

==深入阅读==
{{refbegin | 2}}
*{{cite journal | author = Carpenter G | title = Receptors for epidermal growth factor and other polypeptide mitogens | journal = Annu. Rev. Biochem. | volume = 56 | issue = 1 | pages = 881–914 | year = 1987 | pmid = 3039909 | doi = 10.1146/annurev.bi.56.070187.004313 }}
*{{cite journal | author = Boonstra J, Rijken P, Humbel B, ''et al.'' | title = The epidermal growth factor | journal = Cell Biol. Int. | volume = 19 | issue = 5 | pages = 413–30 | year = 1995 | pmid = 7640657 | doi = 10.1006/cbir.1995.1086 }}
*{{cite journal | author = Carpenter G | title = The EGF receptor: a nexus for trafficking and signaling | journal = BioEssays | volume = 22 | issue = 8 | pages = 697–707 | year = 2000 | pmid = 10918300 | doi = 10.1002/1521-1878(200008)22:8<697::AID-BIES3>3.0.CO;2-1 }}
*{{cite journal | author = Filardo EJ | title = Epidermal growth factor receptor (EGFR) transactivation by estrogen via the G-protein-coupled receptor, GPR30: a novel signaling pathway with potential significance for breast cancer | journal = J. Steroid Biochem. Mol. Biol. | volume = 80 | issue = 2 | pages = 231–8 | year = 2002 | pmid = 11897506 | doi = 10.1016/S0960-0760(01)00190-X }}
*{{cite journal | author = Tiganis T | title = Protein tyrosine phosphatases: dephosphorylating the epidermal growth factor receptor | journal = IUBMB Life | volume = 53 | issue = 1 | pages = 3–14 | year = 2002 | pmid = 12018405 | doi = 10.1080/15216540210811 }}
*{{cite journal | author = Di Fiore PP, Scita G | title = Eps8 in the midst of GTPases | journal = Int. J. Biochem. Cell Biol. | volume = 34 | issue = 10 | pages = 1178–83 | year = 2002 | pmid = 12127568 | doi = 10.1016/S1357-2725(02)00064-X }}
*{{cite journal | author = Benaim G, Villalobo A | title = Phosphorylation of calmodulin. Functional implications | journal = Eur. J. Biochem. | volume = 269 | issue = 15 | pages = 3619–31 | year = 2002 | pmid = 12153558 | doi = 10.1046/j.1432-1033.2002.03038.x }}
*{{cite journal | author = Leu TH, Maa MC | title = Functional implication of the interaction between EGF receptor and c-Src | journal = Front. Biosci. | volume = 8 | issue = 1-3 | pages = s28–38 | year = 2004 | pmid = 12456372 | doi = 10.2741/980 }}
*{{cite journal | author = Anderson NL, Anderson NG | title = The human plasma proteome: history, character, and diagnostic prospects | journal = Mol. Cell Proteomics | volume = 1 | issue = 11 | pages = 845–67 | year = 2003 | pmid = 12488461 | doi = 10.1074/mcp.R200007-MCP200 }}
*{{cite journal | author = Kari C, Chan TO, Rocha de Quadros M, Rodeck U | title = Targeting the epidermal growth factor receptor in cancer: apoptosis takes center stage | journal = Cancer Res. | volume = 63 | issue = 1 | pages = 1–5 | year = 2003 | pmid = 12517767 | doi =  }}
*{{cite journal | author = Bonaccorsi L, Muratori M, Carloni V, ''et al.'' | title = Androgen receptor and prostate cancer invasion | journal = Int. J. Androl. | volume = 26 | issue = 1 | pages = 21–5 | year = 2003 | pmid = 12534934 | doi = 10.1046/j.1365-2605.2003.00375.x }}
*{{cite journal | author = Reiter JL, Maihle NJ | title = Characterization and expression of novel 60-kDa and 110-kDa EGFR isoforms in human placenta | journal = Annals of the New York Academy of Sciences | volume = 995 | issue = 1 | pages = 39–47 | year = 2003 | pmid = 12814937 | doi = 10.1111/j.1749-6632.2003.tb03208.x }}
*{{cite journal | author = Adams TE, McKern NM, Ward CW | title = Signalling by the type 1 insulin-like growth factor receptor: interplay with the epidermal growth factor receptor | journal = Growth Factors | volume = 22 | issue = 2 | pages = 89–95 | year = 2005 | pmid = 15253384 | doi = 10.1080/08977190410001700998 }}
*{{cite journal | author = Ferguson KM | title = Active and inactive conformations of the epidermal growth factor receptor | journal = Biochem. Soc. Trans. | volume = 32 | issue = Pt 5 | pages = 742–5 | year = 2005 | pmid = 15494003 | doi = 10.1042/BST0320742 }}
*{{cite journal | author = Chao C, Hellmich MR | title = Bi-directional signaling between gastrointestinal peptide hormone receptors and epidermal growth factor receptor | journal = Growth Factors | volume = 22 | issue = 4 | pages = 261–8 | year = 2005 | pmid = 15621729 | doi = 10.1080/08977190412331286900 }}
*{{cite journal | author = Carlsson J, Ren ZP, Wester K, ''et al.'' | title = Planning for intracavitary anti-EGFR radionuclide therapy of gliomas. Literature review and data on EGFR expression | journal = J. Neurooncol. | volume = 77 | issue = 1 | pages = 33–45 | year = 2006 | pmid = 16200342 | doi = 10.1007/s11060-005-7410-z }}
*{{cite journal | author = Scartozzi M, Pierantoni C, Berardi R, ''et al.'' | title = Epidermal growth factor receptor: a promising therapeutic target for colorectal cancer | journal = Anal. Quant. Cytol. Histol. | volume = 28 | issue = 2 | pages = 61–8 | year = 2006 | pmid = 16637508 | doi =  }}
*{{cite journal | author = Prudkin L, Wistuba II | title = Epidermal growth factor receptor abnormalities in lung cancer. Pathogenetic and clinical implications | journal = Annals of diagnostic pathology | volume = 10 | issue = 5 | pages = 306–15 | year = 2006 | pmid = 16979526 | doi = 10.1016/j.anndiagpath.2006.06.011 }}
*{{cite journal | author = Ahmed SM, Salgia R | title = Epidermal growth factor receptor mutations and susceptibility to targeted therapy in lung cancer | journal = Respirology | volume = 11 | issue = 6 | pages = 687–92 | year = 2007 | pmid = 17052295 | doi = 10.1111/j.1440-1843.2006.00887.x }}
*{{cite journal | author = Zhang X, Chang A | title = Somatic mutations of the epidermal growth factor receptor and non-small-cell lung cancer | journal = J. Med. Genet. | volume = 44 | issue = 3 | pages = 166–72 | year = 2007 | pmid = 17158592 | pmc = 2598028 | doi = 10.1136/jmg.2006.046102 }}
*{{cite journal | author = Cohenuram M, Saif MW | title = Epidermal growth factor receptor inhibition strategies in pancreatic cancer: past, present and the future | journal = JOP | volume = 8 | issue = 1 | pages = 4–15 | year = 2007 | pmid = 17228128 | doi =  }}
*{{cite journal | author = Mellinghoff IK, Cloughesy TF, Mischel PS | title = PTEN-mediated resistance to epidermal growth factor receptor kinase inhibitors | journal = Clin. Cancer Res. | volume = 13 | issue = 2 Pt 1 | pages = 378–81 | year = 2007 | pmid = 17255257 | doi = 10.1158/1078-0432.CCR-06-1992 }}
*{{cite journal | author = Nakamura JL | title = The epidermal growth factor receptor in malignant gliomas: pathogenesis and therapeutic implications | journal = Expert Opin. Ther. Targets | volume = 11 | issue = 4 | pages = 463–72 | year = 2007 | pmid = 17373877 | doi = 10.1517/14728222.11.4.463 }}
{{refend}}

==外部链接==
* {{MeshName|Epidermal+Growth+Factor+Receptor|3=Epidermal Growth Factor Receptor}}

{{PDB Gallery|geneid=1956}}
{{酪氨酸激酶类|g1}}
{{癌基因}}
{{酶联受体}}
{{生长因子受体}}

[[Category:酪氨酸激酶受体|Category:酪氨酸激酶受体]]
[[Category:癌基因|Category:癌基因]]